[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 20, Issue 1 (Bimonthly 2016) ::
Feyz 2016, 20(1): 57-63 Back to browse issues page
Effect of BMI on anti-Mullerian hormone gene expression in granulosa cells and blood biochemical parameters in patients with polycystic ovary syndrome
Mohammad Nouri , Kazem Gharemanzadh , Hosein Bijanpour , Esmat Aghadavod *
Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I. R, Iran. , Aghadavod@kaums.ac.ir
Abstract:   (1999 Views)

Background: Polycystic ovary syndrome (PCOS) often induces reduced ovulation, infertility and hyperandrogenism. Many PCOS cases manifest different degrees of obesity. The increased body mass index (BMI) may interfere with a successful reproduction. The purpose of this study was to assess the effect of increasing BMI on anti-Mullerian hormone (AMH) gene expression in granulosa cells and also biochemical factors among PCOS cases.

Materials and Methods: This cross-sectional study was carried out on 80 patients (mean age 20-35 y with PCOS or other non-PCOS infertility disorders) referred to Tabriz-Alzahra Fertility Center.  Based on obesity degree and its signs, the cases were divided to four groups. In the same day of isolating oocytes, granulosa cells and serum were taken for gene expression   and the analysis of biochemistry factors, respectively.  

Results: AMH gene expression level were higher in PCOS compared to normal cases (P<0.05). While increasing BMI in the patients didn’t show a significant decrease of AMH gene expression (r=-0.07), a significant positive correlation was observed between AMH and insulin resistance (r= 0.34, P<0.05).

Conclusion: AMH gene expression in PCOS cases is affected by the disease phenotype. Insulin resistance plays an important role in increasing serum AMH.

Keywords: Polycystic ovary syndrome, BMI, Anti-Mullerian hormone, Insulin resistance
Full-Text [PDF 284 kb]   (700 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2016/04/13 | Accepted: 2016/04/13 | Published: 2016/04/13
References
1. Shorakae S, Boyle J, Teede H. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about. Intern Med J 2014; 44(8): 720-6.
2. Nandi A, Chen Z, Patel R, Poretsky L. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 2014; 43(1): 123-47.
3. Murri M, Insenser M, Escobar-Morreale HF. Metabolomics in polycystic ovary syndrome. Clin Chim Acta 2014; 429: 181-8.
4. Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, et al. Polycystic Ovary Syndrome and Anti-Mullerian Hormone: Role of insulin resistance, androgens, obesity and gonadotropins. Clin Endocrinol (Oxf) 2014; 81(6): 132-8.
5. Kazemi A, Hasan Zahraei R, Nasr Esfahani MH, Ahmadi M, Bashardoost N. Comparison of outcome of assisted reproductive methods in patient with polycystic ovaries syndrome and tubal factor. J Shahrekord Univ Med Sci 2006; 8(1): 1-7 (1): 1-7. [in Persian]
6. Kwon SK, Kim SH, Yun SC, Kim DY, Chae HD, Kim CH, et al. Decline of serum antimullerian hormone levels after laparoscopic ovarian cystectomy in endometrioma and other benign cysts: a prospective cohort study. Fertil Steril 2014; 101(2): 435-41.
7. Fonseca HP, Brondi RS, Piovesan FX, Miklos TG, Aldrighi JM. Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome. Gynecol Endocrinol 2014; 30(9): 667-70.
8. Li X, Shao R. PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma. Am J Cancer Res 2014; 4(1): 73-9.
9. Esmaeilzadeh S, Delavar MA, Amiri M, Khafri S, Pasha NG. Polycystic ovary syndrome in Iranian adolescents. Int J Adolesc Med Health 2014; 26(4): 559-65.
10. Niu Z, Lin N, Gu R, Sun Y, Feng Y. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab 2014; 99(11): E2269-76.
11. Chen L, Xu WM, Zhang D. The association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertil Steril 2014; 102(4): 1167-1174.
12. Hojlund K. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Dan Med J 2014; 61(7): B4890.
13. Sunj M, Canic T, Jeroncic A, Karelovic D, Tandara M, Juric S, et al. Anti-Mullerian hormone, testosterone and free androgen index following the dose-adjusted unilateral diathermy in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2014; 179: 163-9.
14. Lan VT, Linh NK, Tuong HM, Wong PC, Howles CM. Anti-Mullerian hormone versus antral follicle count for defining the starting dose of FSH. Reprod Biomed Online 2013; 27(4): 390-9.
15. El-Mazny A, Abou-Salem N. Anti-Mullerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome. Gynecol Endocrinol 2013; 29(9): 826-9.
16. Cankaya S, Demir B, Aksakal SE, Dilbaz B, Demirtas C, Goktolga U. Insulin resistance and its relationship with high molecule weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history. Fertil Steril 2014; 102(3): 826-30.
17. Caserta D, Adducchio G, Picchia S, Ralli E, Matteucci E, Moscarini M. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecol Endocrinol 2014; 30(6): 397-402.
18. Wu S, Divall S, Nwaopara A, Radovick S, Wondisford F, Ko C, et al. Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell. Diabetes 2014; 63(4): 1270-82.
19. Spanos N, Tziomalos K, Macut D, Koiou E, Kandaraki EA, Delkos D, et al. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss. Obesity Facts 2012; 5(4): 495-504.
20. Svendsen PF, Christiansen M, Hedley PL, Nilas L, Pedersen SB, Madsbad S. Adipose expression of adipocytokines in women with polycystic ovary syndrome. Fertil Steril 2012; 98(1): 235-41.
21. Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 2013; 14(2): 95-109.
22. Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab 2013; 17(1): 138-45.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nouri M, Gharemanzadh K, Bijanpour H, Aghadavod E. Effect of BMI on anti-Mullerian hormone gene expression in granulosa cells and blood biochemical parameters in patients with polycystic ovary syndrome. Feyz. 2016; 20 (1) :57-63
URL: http://feyz.kaums.ac.ir/article-1-2975-en.html


Volume 20, Issue 1 (Bimonthly 2016) Back to browse issues page
مجله علمی پژوهشی فیض ::: دانشگاه علوم پزشکی کاشان KAUMS Journal ( FEYZ )
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 3790